CDT Equity Receives Nasdaq Deficiency Letter, Faces July 20 Compliance Deadline
CDT•CDT Equity Inc. received a Nasdaq deficiency notice on May 21 for failing to timely file its Q1 2026 Form 10-Q. Nasdaq grants the company until July 20, 2026 to regain compliance by submitting a plan and completing its 10-Q review.
1. Deficiency Notice Received
On May 21, 2026, CDT Equity Inc. received a written notice from Nasdaq Listing Qualifications for not timely filing its Quarterly Report on Form 10-Q for the period ended March 31, 2026, as required by Rule 5250(c)(1).
2. Compliance Deadline and Listing Status
The notice does not affect current trading of CDT’s securities and provides the company until July 20, 2026 to submit a plan demonstrating how it will regain compliance with the periodic filing requirement.
3. Anticipated 10-Q Filing
CDT expects to complete its internal review of the current draft and file the Q1 2026 Form 10-Q as soon as that process is finished, with the goal of satisfying Nasdaq’s requirements and restoring full compliance.
